Pulse Biosciences (PLSE) Assets Average (2016 - 2025)

Pulse Biosciences' Assets Average history runs 10 years deep, the most recent figure standing at $101.7 million for Q4 2025.

• On a quarterly basis, Assets Average fell 9.85% year-over-year to $101.7 million in Q4 2025; TTM through Dec 2025 was $101.7 million, a 9.85% decrease from a year earlier, with the FY2025 full-year figure at $113.5 million, up 18.47% from the prior year.
• Assets Average fell to $101.7 million in Q4 2025 per PLSE's latest filing, from $114.5 million in the prior quarter.
• Across five years, Assets Average topped out at $132.9 million in Q1 2025 and bottomed at $40.1 million in Q2 2022.
• The 5-year median for Assets Average is $71.4 million (2023), against an average of $77.4 million.
• Across the five-year window, Assets Average plunged 50.1% in 2022 and jumped 183.1% in 2025, its largest moves.
• Year by year, Assets Average stood at $63.2 million in 2021, then soared by 30.99% to $82.7 million in 2022, then fell by 24.39% to $62.5 million in 2023, then soared by 80.26% to $112.8 million in 2024, then retreated by 9.85% to $101.7 million in 2025.
• Per Business Quant, the three latest PLSE Assets Average figures stand at $101.7 million (Q4 2025), $114.5 million (Q3 2025), and $126.8 million (Q2 2025).